Wilson DE, et al. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127: 820-823, 1968. PubMed: 5651140
Fan M, et al. The 5S rRNA and the rRNA intergenic spacer of the two varieties of Cryptococcus neoformans. J. Med. Vet. Mycol. 33: 215-221, 1995. PubMed: 8531018
Brandt ME, et al. Multilocus enzyme typing of Cryptococcus neoformans. J. Clin. Microbiol. 31: 2819-2823, 1993. PubMed: 8253996
Gyetko MR, et al. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. J. Clin. Invest. 97: 1818-1826, 1996. PubMed: 8621764
Mukherjee S, et al. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J. Infect. Dis. 173: 1222-1231, 1996. PubMed: 8627076
Wang Y, et al. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect. Immun. 64: 2420-2424, 1996. PubMed: 8698461
Gross NT, et al. In vitro effect of lung surfactant on alveolar macrophage defence mechanisms against Cryptococcus neoformans. Mycopathologia 144: 21-27, 1999. PubMed: 10422270
Nussbaum G, et al. Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice. Infect. Immun. 67: 4469-4476, 1999. PubMed: 10456888
Fries BC, et al. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect. Immun. 67: 6076-6083, 1999. PubMed: 10531269
Goldman DL, et al. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect. Immun. 68: 832-838, 2000. PubMed: 10639453
Feldmesser M, et al. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68: 4225-4237, 2000. PubMed: 10858240
Feldmesser M, et al. Intracellular crystal formation as a mechanism of cytotoxicity in murine pulmonary Cryptococcus neoformans infection. Infect. Immun. 69: 2723-2727, 2001. PubMed: 11254641
Nakouzi A, et al. Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies. Infect. Immun. 69: 3398-3409, 2001. PubMed: 11292763
Goldman D, et al. Cryptococcus neoformans induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta in human microglia: role of specific antibody and soluble capsular polysaccharide. Infect. Immun. 69: 1808-1815, 2001. PubMed: 11179358
Olszewski MA, et al. Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect. Immun. 69: 6256-6263, 2001. PubMed: 11553568
Beenhouwer DO, et al. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect. Immun. 69: 6445-6455, 2001. PubMed: 11553589
Rosas AL, Casadevall A. Melanization decreases the suseptibility of Cryptococcus neoformans to enzymatic degradation. Mycopathologia 151: 53-56, 2001.
|
